Healthcare - Biotechnology - NASDAQ - US
$ 4.955
-8.92 %
$ 110 M
Market Cap
-2.27
P/E
INCOME STATEMENT
155 K
REVENUE
-29.7 M
OPERATING INCOME
-30 M
NET INCOME
EFFICIENCY
Earnings Waterfall
INmune Bio, Inc.
| Revenue | 155 K |
| Cost Of Revenue | 0 |
| Gross Profit | 155 K |
| Operating Expenses | 29.9 M |
| Operating Income | -29.7 M |
| Other Expenses | 267 K |
| Net Income | -30 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 0.2 | 0.4 | 0.2 | 10.9 K | 77.7 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0.2 | 0.4 | 0.2 | 10.9 K | 77.7 | 0 | 0 | 0 | 0 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 29.9 | 26.3 | 29.3 | 12.2 | 9.3 | 12.4 | 1.0 | 0.2 | 48.9 K |
| Selling, General and Administrative Expenses | 9.6 | 9.3 | 8.8 | 6.3 | 6.0 | 11.3 | 0.5 | 0.1 | 48.9 K |
| Research and Development Expenses | 20.3 | 17.1 | 20.5 | 5.9 | 3.3 | 1.1 | 0.4 | 0.1 | 0 |
| Operating Income | (29.7) | (26.0) | (29.2) | (12.2) | (7.8) | (12.4) | (1.0) | (0.2) | 48.9 K |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | 1.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (0.3) | (1.3) | (1.2) | 0.1 | 77.7 K | 0 | 0.1 | 50 K | 0 |
| Pre-Tax Income | (30.0) | (27.3) | (30.3) | (12.1) | (7.7) | (12.4) | (0.8) | (0.3) | 48.9 K |
| NET INCOME | |||||||||
| Tax Provision | 0 | 1.3 | (29.2) | (12.2) | 1.5 | (0.2) | (1.1) | (0.2) | 0 |
| Net Income | (30.0) | (28.6) | (30.3) | (12.1) | (9.1) | (12.4) | (0.8) | (0.3) | 48.9 K |
| EPS | 1.67 | 1.6 | 1.88 | 1.01 | 0.89 | 1.11 | 0.0741 | 0.0247 | 0.0044 |